SCHEMBL4184835

SCHEMBL4184835

COc1cccc(OC)c1C=C(C(N)=O)S(=O)(=O)Cc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ ATM Q13315 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PKM P14618 1/20 0.37
▸ EGFR P00533 3/20 0.37
▸ ERBB2 P04626 3/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184824 1.00 BRAF (0.43) BRAFALDH1A1LMNAHSD17B10MAPT
SCHEMBL4184829 1.00 BRAF (0.43) BRAFALDH1A1LMNAHSD17B10MAPT
SCHEMBL4184830 0.89 EGFR (0.39) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL4184837 0.89 EGFR (0.39) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL4184825 0.89 EGFR (0.39) ALDH1A1LMNAHSD17B10MAPTTP53
SCHEMBL4172163 0.88 EGFR (0.40) BRAFLMNAMAPTKDM4EGAA
SCHEMBL4172167 0.88 EGFR (0.40) BRAFLMNAMAPTKDM4EGAA
SCHEMBL4172157 0.88 EGFR (0.40) BRAFLMNAMAPTKDM4EGAA
SCHEMBL4179107 0.79 LMNA (0.41) ALDH1A1LMNAMAPTHTTSMN1; SMN2
SCHEMBL4179112 0.79 LMNA (0.41) ALDH1A1LMNAMAPTHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 BRAF 372/4885ALDH1A1 249/4885LMNA 4621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback